Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Arcutis Biotherapeutics Q3 EPS $0.06 Beats $(0.10) Estimate, Sales $99.219M Beat $86.978M Estimate

Author: Benzinga Newsdesk | October 28, 2025 08:31am
Arcutis Biotherapeutics (NASDAQ:ARQT) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $(0.10) by 161.86 percent. This is a 118.18 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $99.219 million which beat the analyst consensus estimate of $86.978 million by 14.07 percent. This is a 121.69 percent increase over sales of $44.755 million the same period last year.

Posted In: ARQT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist